{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:46:16Z","timestamp":1792277176826,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1995,5,1]],"date-time":"1995-05-01T00:00:00Z","timestamp":799286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[1995,5]]},"DOI":"10.4065\/70.5.481","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T20:01:56Z","timestamp":1232740916000},"page":"481-487","source":"Crossref","is-referenced-by-count":49,"title":["Aspirin Idiosyncrasy in Systemic Mast Cell Disease: A New Look at Mediator Release During Aspirin Desensitization"],"prefix":"10.4065","volume":"70","author":[{"given":"Joseph H.","family":"Butterfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pai C.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Klee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Yocum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/70.5.481_bib1","first-page":"400","article-title":"Increased production of prostaglandin D2 in patients with systemic mastocytosis","volume":"303","author":"Roberts","year":"1980","journal-title":"N Engl J Mcd"},{"key":"10.4065\/70.5.481_bib2","first-page":"141","article-title":"Markedly increased synthesis of prostaglandin D2 in systemic mastocytosis","volume":"93","author":"Roberts","year":"1980","journal-title":"Trans Assoc Am Physicians"},{"key":"10.4065\/70.5.481_bib3","first-page":"18","article-title":"The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production","volume":"26","author":"Koottc","year":"1983","journal-title":"NethJMed"},{"key":"10.4065\/70.5.481_bib4","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12499963","article-title":"Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans","volume":"98","author":"Morrow","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.4065\/70.5.481_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-6980(89)90088-9","article-title":"Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid","volume":"38","author":"Morrow","year":"1989","journal-title":"Prostaglandins"},{"key":"10.4065\/70.5.481_bib6","first-page":"145","article-title":"Shock syndrome associated with mastocylosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks","volume":"8","author":"Roberts","year":"1982","journal-title":"Adv Shock Res"},{"key":"10.4065\/70.5.481_bib7","first-page":"36","article-title":"Mastocytosis without urticaria pigmentosa: a frequently unrecognized cause of recurrent syncope","volume":"95","author":"Roberts","year":"1982","journal-title":"Trans Asset Am Physicians"},{"key":"10.4065\/70.5.481_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(57)91395-8","article-title":"Release of histamine in urticaria pigmentosa","volume":"1","author":"Hamrin","year":"1957","journal-title":"Lancet"},{"key":"10.4065\/70.5.481_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archderm.1962.01590080087011","article-title":"Histamine liberation by codeine and polymyxin B in urticaria pigmentosa","volume":"86","author":"Slitter","year":"1962","journal-title":"Arch Dermatol"},{"key":"10.4065\/70.5.481_bib10","first-page":"1","article-title":"Systemic mastocytosis: management of an unusual case with histamine (HI and H2) antagonists and cyclooxygenase inhibition","volume":"10","author":"Crawhall","year":"1987","journal-title":"Clin Invest Mod"},{"key":"10.4065\/70.5.481_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0167-5699(90)90176-A","article-title":"Mast cells as a source of multifunctional cytokines","volume":"11","author":"Gordon","year":"1990","journal-title":"Immunol Today"},{"key":"10.4065\/70.5.481_bib12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0025-6196(12)61825-4","article-title":"Increased plasma calcitonin levels in systemic mast cell disease","volume":"69","author":"Yocum","year":"1994","journal-title":"Mayo Gin Proc"},{"key":"10.4065\/70.5.481_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(91)90062-K","article-title":"A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies","volume":"138","author":"Enander","year":"1991","journal-title":"J Immunol Methods"},{"key":"10.4065\/70.5.481_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0025-6196(12)65441-X","article-title":"Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests","volume":"62","author":"Gharib","year":"1987","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/70.5.481_bib15","first-page":"740","article-title":"Regional distribution and characterization of the brain-gut peptide: calcitonin genc-relatcd peptide (CGRP) in pig [abstract]","volume":"15","author":"Roddy","year":"1989","journal-title":"Sot Neurosci Abslr"},{"key":"10.4065\/70.5.481_bib16","first-page":"271","article-title":"Structure and function of the chemical mediators of mast cells","volume":"34","author":"Schwartz","year":"1984","journal-title":"Prog Allergy"},{"key":"10.4065\/70.5.481_bib17","first-page":"213","article-title":"The Ccells (parafollicular cells) of the thyroid gland and medullary thyroid carcinoma: a review","volume":"88","author":"Hazard","year":"1977","journal-title":"Am J Palhol"},{"key":"10.4065\/70.5.481_bib18","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/1097-0142(197511)36:5<1758::AID-CNCR2820360531>3.0.CO;2-J","article-title":"The oxyphil and C eeils of the human thyroid gland: a eytochemical and histopathologic review","volume":"36","author":"Roediger","year":"1975","journal-title":"Cancer"},{"key":"10.4065\/70.5.481_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.0954-6820.1984.tb05007.x","article-title":"Hypercalcitoninaemia in a patient with urticaria pigmentosa: a possible cause of diarrhoea","volume":"215","author":"Lundin","year":"1984","journal-title":"Acta Med Scand"},{"key":"10.4065\/70.5.481_bib20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1210\/jcem-46-4-567","article-title":"Comparative effect of calcium and of the adrener-gic system on calcitonin secretion in man","volume":"46","author":"Vora","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/70.5.481_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/jcem-47-1-151","article-title":"Neuroendocrinc modulation of calcitonin and parathyroid hormone in man","volume":"47","author":"Metz","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/70.5.481_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/10408369009105900","article-title":"The calcitonin gene peptides: biology and clinical relevance","volume":"28","author":"Zaidi","year":"1990","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.4065\/70.5.481_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/298240a0","article-title":"Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypcptide products","volume":"298","author":"Amara","year":"1982","journal-title":"Nature"},{"key":"10.4065\/70.5.481_bib24","first-page":"54","article-title":"Calcitonin gene-related peptide is a potent vasodilator","volume":"313","author":"Brain","year":"1985","journal-title":"Nalure"},{"key":"10.4065\/70.5.481_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0002-8703(92)90754-J","article-title":"Vasodilating actions of calcitonin gene-related peptide in normal man: comparison with atrial natriuretic peplide","volume":"123","author":"Ando","year":"1992","journal-title":"Am Heart J"},{"key":"10.4065\/70.5.481_bib26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.1988.tb05306.x","article-title":"Human alpha-calcitonin gene-related peptide (CGRP) is a potent vasodilator in human mesenteric vasculature","volume":"26","author":"Marshall","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.4065\/70.5.481_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-2999(87)90187-7","article-title":"Calcitonin gene-related peptide: a potent modulator of coronary How","volume":"137","author":"Ezra","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.4065\/70.5.481_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410230214","article-title":"Release of vasoactive peptides in the cxtracerebral circulation of humans and the cat during activation of thetrigcminovascularsystem","volume":"23","author":"Goadsby","year":"1988","journal-title":"Ann Neurol"},{"key":"10.4065\/70.5.481_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0090-6980(84)90033-9","article-title":"Effects of intravenous infusions of prostaglandin D2 in man","volume":"28","author":"Heavey","year":"1984","journal-title":"Prostaglandins"},{"key":"10.4065\/70.5.481_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0014-2999(85)90456-X","article-title":"Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin","volume":"108","author":"Lundberg","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.4065\/70.5.481_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/cs0740413","article-title":"Haemodynamic effects of intravenous human calcitonin-genc-related peptide in man","volume":"74","author":"Howden","year":"1988","journal-title":"Clin Sci (Lond)"},{"key":"10.4065\/70.5.481_bib32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF02554909","article-title":"Cardiovascular action of calcitonin gene-related peptide in humans","volume":"37","author":"Gennari","year":"1985","journal-title":"Calcif Tissue Int"},{"key":"10.4065\/70.5.481_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/cs0700389","article-title":"Human calcitonin gene related peptide: a potent endogenous vasodilator in man","volume":"70","author":"Strulhers","year":"1986","journal-title":"Clin Sci (Lond)"},{"key":"10.4065\/70.5.481_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-0115(86)90071-6","article-title":"Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects","volume":"15","author":"Uddman","year":"1986","journal-title":"Regul Pept"},{"key":"10.4065\/70.5.481_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0014-2999(85)90616-8","article-title":"Circulating CGRP comes from the perivascular nerves","volume":"117","author":"Zaidi","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.4065\/70.5.481_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0090-6980(77)90004-1","article-title":"Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets","volume":"13","author":"Oelz","year":"1977","journal-title":"Prostaglandins"},{"key":"10.4065\/70.5.481_bib37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0091-6749(84)90381-6","article-title":"Inflammatory mediators and mechanisms of release from purified human basophils and mast cells","volume":"74","author":"Schleimer","year":"1984","journal-title":"J Allergy Clin Immunol"},{"key":"10.4065\/70.5.481_bib38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0090-6980(88)90093-7","article-title":"The biology and pharmacology of PGD2","volume":"35","author":"Giles","year":"1988","journal-title":"Prostaglandins"},{"key":"10.4065\/70.5.481_bib39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0090-6980(77)90007-7","article-title":"Bronchopulmonary and cardiovascular effects of prostaglandin D2 in the dog","volume":"13","author":"Wasserman","year":"1977","journal-title":"Prostaglandins"},{"key":"10.4065\/70.5.481_bib40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ajh\/6.5.434","article-title":"Calcitonin gene-related peptide and regulation of human cardiovascular homeostasis","volume":"6","author":"Preibisz","year":"1993","journal-title":"Am J Hyperions"},{"key":"10.4065\/70.5.481_bib41","first-page":"117","article-title":"Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for hacmodialysis in comparison with prostaglandin El (PGE1)","volume":"18","author":"Nakagawa","year":"1981","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"10.4065\/70.5.481_bib42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01965102","article-title":"Increased urinary methylimidazoleacetic acid (MelmAA) as an indicator of systemic mastocytosis","volume":"12","author":"Granerus","year":"1982","journal-title":"Agents Actions"},{"key":"10.4065\/70.5.481_bib43","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1056\/NEJM198312293092603","article-title":"Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites","volume":"309","author":"Keyzer","year":"1983","journal-title":"NEnglJMed"},{"key":"10.4065\/70.5.481_bib44","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis","volume":"316","author":"Schwaru","year":"1987","journal-title":"NEnglJMed"},{"key":"10.4065\/70.5.481_bib45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1476-5381.1985.tb11107.x","article-title":"Inflammatory oedema induced by synergism between calcitonin gene related peptide (CGRP) and mediators of increased vascular permeability","volume":"86","author":"Brain","year":"1985","journal-title":"BrJ Pharmacol"},{"key":"10.4065\/70.5.481_bib46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/endo-119-1-381","article-title":"Specific receptor and cardiovascular effects of calcitonin gcnc-rclatcd peplide","volume":"119","author":"Sigrisl","year":"1986","journal-title":"Endocrinology"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611638883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611638883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T03:54:32Z","timestamp":1545450872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611638883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,5]]}},"alternative-id":["S0025619611638883"],"URL":"https:\/\/doi.org\/10.4065\/70.5.481","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[1995,5]]}}}